Skip to main content

Table 3 Spending on R&Da and promotion as a percent of sales for companies with the most heavily promoted drugs

From: Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis

Year

Number of companiesb

Number of drugs

Total sales ($000)

R&D spending ($000)

(% sales)

Promotion spending ($000)

(% sales)

Ratio of R&D to promotion spending

Number of companies spending more on promotion than on R&D

2013

22

46

12,761,798

565,670 (4.4)

243,420 (1.9)

2.32

9

2014

22

46

13,327,819

509,531 (3.8)

242,401 (1.8)

2.11

8

2015

22

45

13,215,385

487,223 (3.7)

230,157 (1.7)

2.18

9

2016

22

49

13,610,805

553,057 (4.1)

258,363 (1.9)

2.16

10

  1. aResearch and development
  2. bIndividual companies vary by year